Guide RNA structure design enables combinatorial CRISPRa programs for biosynthetic profiling
Authors:
- Jason FontanaJFJason Fontana
- Ian FaulknerIFIan Faulkner
- Ryan CardiffRCRyan Cardiff
- Cholpisit KiattiseweeCKCholpisit Kiattisewee
- Aria WallsAWAria Walls
- Tommy G. PrimoTPTommy G. Primo
- Patrick C. KinnunenPKPatrick C. Kinnunen
- Hector Garcia MartinHMHector Garcia Martin
- Jesse G. ZalatanJZJesse G. Zalatan
- James M. CarothersJCJames M. Carothers
Open Access
- 27 July 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Abstract
Engineering metabolism to efficiently produce chemicals from multi-step pathways requires optimizing multi-gene expression programs to achieve enzyme balance. CRISPR-Cas transcriptional control systems are emerging as important tools for programming multi-gene expression, but poor predictability of guide RNA folding can disrupt expression control. Here, we correlate efficacy of modified guide RNAs (scRNAs) for CRISPR activation (CRISPRa) in E. coli with a computational kinetic parameter describing scRNA folding rate into the active structure (rS = 0.8). This parameter also enables forward design of scRNAs, allowing us to design a system of three synthetic CRISPRa promoters that can orthogonally activate (>35-fold) expression of chosen outputs. Through combinatorial activation tuning, we profile a three-dimensional design space expressing two different biosynthetic pathways, demonstrating variable production of pteridine and human milk oligosaccharide products. This RNA design approach aids combinatorial optimization of metabolic pathways and may accelerate routine design of effective multi-gene regulation programs in bacterial hosts.Keywords
All Related Versions
Funding Information
- National Science Foundation (MCB 1817623, MCB 2032794, CBET 1844152)
- U.S. Department of Energy (DE-EE0008927, DE-SC0023091)
- BASF | BASF Corporation
This publication has 111 references indexed in Scilit:
- The Diverse Antimicrobial Activities of Human Milk Oligosaccharides against Group B StreptococcusChemBioChem, 2021
- Metabolic engineering of Escherichia coli for the production of Lacto-N-neotetraose (LNnT)Systems Microbiology and Biomanufacturing, 2021
- Therapeutic potential of pteridine derivatives: A comprehensive reviewMedicinal Research Reviews, 2018
- Regulated Expression of sgRNAs Tunes CRISPRi in E. coliBiotechnology Journal, 2018
- Chromatin accessibility and guide sequence secondary structure affect CRISPR‐Cas9 gene editing efficiencyFEBS Letters, 2017
- Computational Design of RNA Parts, Devices, and Transcripts with Kinetic Folding Algorithms Implemented on Multiprocessor Clusters2014
- Synthesis of the Human Milk Oligosaccharide Lacto‐N‐Tetraose in Metabolically Engineered, Plasmid‐Free E. coliChemBioChem, 2014
- Determination of marker pteridins and biopterin reduced forms, tetrahydrobiopterin and dihydrobiopterin, in human urine, using a post-column photoinduced fluorescence liquid chromatographic derivatization methodAnalytica Chimica Acta, 2009
- Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuriaAmerican Journal of Medical Genetics Part A, 2008
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985